Sponsored content on Regulatory News

Reach regulatory and quality professionals mid-task — in a publication that labels paid content plainly and reviews it before it runs.

Regulatory News is read by the people who prepare submissions, run quality systems, and track FDA, EMA, MHRA and EU MDR/IVDR developments for a living. A sponsored article puts your expertise in front of them in the same format they already read — sourced, edited, and permanent at its own URL.

Two things we sell, and one we don’t. You get placement and our editorial floor: every sponsored article is reviewed for accuracy and usefulness before it runs. You do not get our voice — sponsored articles are labeled Sponsored Content on the page, in the feed, and in the data machines read, and they never appear in Top Stories, the hero, or any slot our editors curate. That separation is why placement here is worth buying. The full rules are public: how sponsored content works.

Rates

Prices in USD. Payment is by secure payment link after editorial acceptance — you are never charged for an article we decline.

How it works

1. Submit below. Send a draft, an outline, or just the topic — with your company and the tier you have in mind.
2. Editorial review. Within five business days an editor accepts, requests changes, or declines. We decline anything misleading, unsourced, or indistinguishable from an ad.
3. Payment. On acceptance you receive a secure payment link. Publication is scheduled once payment clears.
4. Publication. The article goes live with Sponsored labeling, your company named as the source, and a permanent URL you can link from anywhere.

Start a submission